Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.
about
204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The NetherlandsApplication of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy researchProteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy.Skeletal muscle secretome in Duchenne muscular dystrophy: a pivotal anti-inflammatory role of adiponectin.Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophiesDiscovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia.Simultaneous Pathoproteomic Evaluation of the Dystrophin-Glycoprotein Complex and Secondary Changes in the mdx-4cv Mouse Model of Duchenne Muscular DystrophySerum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.Cancer cachexia causes skeletal muscle damage via transient receptor potential vanilloid 2-independent mechanisms, unlike muscular dystrophyConcurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles.Changes in Communication between Muscle Stem Cells and their Environment with Aging.Chaperoning heat shock proteins: proteomic analysis and relevance for normal and dystrophin-deficient muscle.Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy.Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis.Mass spectrometry-based protein analysis to unravel the tissue pathophysiology in Duchenne muscular dystrophy.Obestatin controls skeletal muscle fiber-type determination.Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation.Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis.Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients.Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles.Expression and modification proteomics during skeletal muscle ageing.β-Arrestin scaffolds and signaling elements essential for the obestatin/GPR39 system that determine the myogenic program in human myoblast cells.Exosomes exert cardioprotection in dystrophin-deficient cardiomyocytes via ERK1/2-p38/MAPK signaling
P2860
Q28611318-34A16F1E-CB4D-4CDF-9F62-3AEC21ECC782Q33565229-5DBC59E4-352C-4CB8-81E2-DA0724409B3DQ33675040-27AD65DD-9974-4967-B1FE-9BDA63CACFF4Q33844548-4891768E-0DAF-454B-9FA9-1397DFA0AE00Q33991470-9591C23D-9CBE-439D-8CF2-1105AB9F7D88Q34555477-17958CAD-1DA6-4D8A-8713-F86F603E2C07Q35616824-E704A8B0-244D-4704-A1ED-EF656E719F91Q35837856-BA7AC7E1-154B-4E42-8175-C37B3E50B314Q35924068-5D3EAD42-5354-47AE-8C3C-2D43F7B5F85AQ36422465-A75EF7A2-0D93-40B8-939C-811BDA603339Q36893355-B43E1222-F273-4A35-AE4D-1BD5201D36AFQ37566483-F3D8D1AA-F7A5-47CC-A428-0CDE8D52A0C1Q37589632-8C69B16B-57C7-4A97-934A-96A9DCAD0D12Q38217473-CFCDD0D0-B83A-4EC3-A691-7015795A1616Q38302852-0A47E159-DCBA-4AC8-AAC5-CD0323015B69Q38563300-41A9A3EE-0AFA-4BE5-92AB-B315305BFE05Q38717697-A31B75FF-31D6-4E26-8988-09C0E6646DA0Q38775930-D5E6A704-2EF6-44F5-B34F-3851700F33A7Q38850056-8880AB00-0DA8-4646-A32B-C750F6BDB5BEQ39033229-AC4D4EC2-AC93-45C4-B8D6-52FDE759186CQ40198410-2D3E36A8-854E-4756-B38F-DD905E3BC34DQ40667121-548548B6-40DC-49A4-8F65-A3AF46B9CFF0Q43845244-3B283990-36C3-4A3F-AC3A-18E2DF99B8ADQ52928223-01B09A21-EF2C-41E6-9CF2-92F88E6DE874Q58589843-61DC3EBC-6E93-40E3-B5B5-C8B8C2664828
P2860
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.
@en
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.
@nl
type
label
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.
@en
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.
@nl
prefLabel
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.
@en
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.
@nl
P2093
P2860
P50
P1476
Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion.
@en
P2093
Helen Johnston
Jeanne Lainé
Marie Catherine Le Bihan
Terence Partridge
Yetrib Hathout
P2860
P2888
P304
P356
10.1007/S00018-012-1248-2
P577
2013-01-24T00:00:00Z